Richard A. Frey

DOPPL SA is a spin out of SUN bioscience SA and a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.

SUN bioscience is enabling personalized medicine through its SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. Our flagship technology Gri3D® is solving the challenges of organoid culture: automation, robustness, scalability, and easy imaging. This will introduce a new era in drug development.

We are a group of seasoned legal and technical IP experts ready to provide disruptive IP solutions and strategies to our clients. Quality, reliability and efficiency are our firm’s pillars. Our competitive rates allow our clients to have access to top legal and technical IP services, optimizing their resources and focusing on their business. ​ Our firm owns a unique blend of experience, built on the many in-house challenges and strategies developed when dealing with competition and financial constraints. We are therefore able to offer you: * One key contact, one invoice. One-stop solution for national, regional and international IP protection * Professional IP Attorneys and specialists qualified in chemistry, mechanical engineering, electronics, material science and other areas of technology and science " A team of skilled and experienced translators with technical and scientific background and trained in IP Quality, timely, detail oriented and cost-effective IP assistance

MoreThan Capital is a global investment and advisory firm founded and backed by a powerful community of 100+ business leaders and professional investors. Our mission is to leverage our global community to select, invest in and help grow companies committed to leading change and creating impact. Our goal is to realize outsized returns for our members and investors in an accelerated time horizon by providing our portfolio companies with capital, expertise and access to our unique network and by being their true partners and dedicated advisors with skin in the game. Beyond committing time and energy to help great Founders succeed, our community members are the initial investors in our Luxembourg-based MTC Fund I, that follows an industry agnostic strategy and invests globally in companies that are on the verge of expansion, scaling up and entering new markets. The Fund is open to select external investors who share our vision and values and who believe in the power of networks and a hands-on investment approach.

DOPPL SA is a spin out of SUN bioscience SA and a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.

SUN bioscience is enabling personalized medicine through its SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. Our flagship technology Gri3D® is solving the challenges of organoid culture: automation, robustness, scalability, and easy imaging. This will introduce a new era in drug development.

We are a group of seasoned legal and technical IP experts ready to provide disruptive IP solutions and strategies to our clients. Quality, reliability and efficiency are our firm’s pillars. Our competitive rates allow our clients to have access to top legal and technical IP services, optimizing their resources and focusing on their business. ​ Our firm owns a unique blend of experience, built on the many in-house challenges and strategies developed when dealing with competition and financial constraints. We are therefore able to offer you: * One key contact, one invoice. One-stop solution for national, regional and international IP protection * Professional IP Attorneys and specialists qualified in chemistry, mechanical engineering, electronics, material science and other areas of technology and science " A team of skilled and experienced translators with technical and scientific background and trained in IP Quality, timely, detail oriented and cost-effective IP assistance